23 April 2009
No improvement in studies reporting the diagnostic accuracy of B-type natriuretic peptide
Lukasz J. KrzychABCDEFG, Lukasz LiszkaACDFMed Sci Monit 2009; 15(5): SR5-14 :: ID: 869624
Abstract
Background
B-type natriuretic peptides (BNP and NT-proBNP) appeared as important tools for diagnosis, risk stratification, and therapeutic decision making in cardiovascular diseases. The aim of the study was to assess fulfillment of the QUADAS and major STARD criteria in B-type natriuretic peptide diagnostic accuracy studies and describe the relationship between the year of study publication. the journal's impact factor, and the quality of diagnostic accuracy.
Material and Method
In a cross-sectional study, electronic and manual searches of MEDLINE and EMBASE databases from January 2004 through April 2007 for diagnostic accuracy studies of BNP and NT-proBNP were performed. The quality of articles was assessed using of the 14-item QUADAS tool supplemented by a subjectively prepared list of 8 less reproducible STARD criteria (total of 22 possible points).
Results
Twenty-eight articles suitable for analysis were found. The median number of points was 15. Only 2 of the 28 articles satisfied all 22 criteria. Clinical data availability was the only item described sufficiently in all papers. A flow diagram was found in only one paper. There were no differences in article quality in relation to the year of publication and no association between article quality and the impact factor of the journal in which it was published.
Conclusions
Imperfect quality of studies reporting the diagnostic accuracy of B-type natriuretic peptides is related to neither the year of publication nor the journal's impact factor. The problem of reporting diagnostic accuracy cannot be neglected, especially when a new index test becomes common in clinical practice.
Keywords: Natriuretic Peptide, Brain - blood, journal impact factor, Diagnosis, Cross-Sectional Studies
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952